Novel vanilloid receptor-1 antagonists: 2. Structure-activity relationships of 4-oxopyrimidines leading to the selection of a clinical candidate.
暂无分享，去创建一个
N. Chen | J. Treanor | C. Dominguez | J. Katon | E. Doherty | C. Fotsch | A. Bannon | Yunxin Y Bo | J. Falsey | N. Gavva | Thomas E. Nixey | V. Ognyanov | L. Pettus | R. Rzasa | Markian M Stec | S. Surapaneni | Rami Tamir | Jiawang Zhu | M. Norman | R. Tamir | M. H. Norman | James R. Falsey